These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 510337)

  • 1. The mode of action of the antitumour agent GP 48,989 in the rat.
    Jordan VC; Dixon B; Prestwich G; Furr BJ
    Eur J Cancer (1965); 1979 May; 15(5):755-61. PubMed ID: 510337
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment in vivo of R3230AC carcinoma of the rat with estradiol mustard (NSC-112259) of its molecular components.
    Everson RB; Hall TC; Wittliff JL
    Cancer Chemother Rep; 1973; 57(3):353-5. PubMed ID: 4751260
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas.
    Rose DP; Fischer AH; Jordan VC
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):893-8. PubMed ID: 7198978
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
    Ip MM; Sylvester PW; Schenkel L
    Cancer Res; 1986 Apr; 46(4 Pt 1):1735-40. PubMed ID: 3948162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on the establishment of a mammary adenocarcinoma MA--737 (author's transl)].
    Sun WY; Ma KS; Guan JF
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):168-73. PubMed ID: 7227180
    [No Abstract]   [Full Text] [Related]  

  • 6. Epithioandrostanol on mammary tumors of rats and mice.
    Takatani O; Kumaoka S; Yamaguchi K
    Gan; 1973 Jun; 64(3):305-7. PubMed ID: 4730599
    [No Abstract]   [Full Text] [Related]  

  • 7. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
    Ip MM; Milholland RJ; Rosen F; Kim U
    Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
    Sonnenschein C; Ucci AA; Soto AM
    J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of "hormone-independent" DMBA-induced mammary carcinomas in response to GP 48989 and its effects on hormone receptors.
    Schmidt-Ruppin KH; Joss U; Schieweck K
    Oncology; 1976; 33(5-6):229-31. PubMed ID: 829153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas.
    Iino Y; Takai Y; Sugamata N; Morishita Y
    Anticancer Res; 1992; 12(6B):2101-3. PubMed ID: 1295453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen tolerance and steroid receptors in a tumor model.
    Kellen JA; Sutherland DJ
    In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptors in transplantable ovary-independent, mammary tumours of the rat.
    Hawkins RA; Hill A; Freedman B; Killen E; Miller WR
    Eur J Cancer (1965); 1978 Jan; 14(1):83-90. PubMed ID: 414923
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of insulin and estrogen on hormone binding in the R3230AC mammary adenocarcinoma.
    Shafie SM; Gibson SL; Hilf R
    Cancer Res; 1977 Dec; 37(12):4641-9. PubMed ID: 922744
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the efficacy for antitumor activity of the non-steroidal antiestrogens analog II and tamoxifen in 7,12-dimethylbenz[a] anthracene-induced rat mammary tumors.
    Pento JT; Magarian RA; King MM
    Cancer Lett; 1982; 15(3):261-9. PubMed ID: 6811128
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-tumour potential of a new luteinizing hormone releasing hormone analogue, ICI 118630.
    Nicholson RI; Walker KJ; Maynard PV
    Eur J Cancer (1965); 1980; Suppl 1():295-9. PubMed ID: 6459236
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents.
    Sandberg J; Goldin A
    Cancer Chemother Rep; 1971 Jun; 55(3):233-8. PubMed ID: 5115845
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
    Yamamoto H; Morimoto T; Monden A
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1786-92. PubMed ID: 2512479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estrogenic and antineoplastic activity of a series of transformed analogs of estrone and estradiol].
    Sorokina IB; Barkova TI; Zakharychev AA; Chigir' RN; Ananchenko SN
    Izv Akad Nauk SSSR Biol; 1973; 5():664-70. PubMed ID: 4761310
    [No Abstract]   [Full Text] [Related]  

  • 20. Mammary tumor regression. II. Autophagy of neoplastic cells.
    Gullino PM; Lanzerotti RH
    J Natl Cancer Inst; 1972 Nov; 49(5):1349-56. PubMed ID: 4650199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.